API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.otsuka.co.jp/en/company/newsreleases/2024/20240209_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-cuts-price-of-cardiovascular-drug-cidmus/articleshow/97091194.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-heart-drug-price-may-fall-by-60-on-generic-rollouts/articleshow/97102183.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-reserves-order-on-natcos-plea-over-patent-for-novartis-drug/articleshow/96920043.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://health.economictimes.indiatimes.com/news/pharma/top-novartis-cardiac-drug-to-go-off-patent/95952280
https://www.fiercepharma.com/pharma/novartis-takes-entresto-generic-fight-fda-again-after-similar-appeal-flopped-april
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-restrains-generic-pharma-firms-from-making-selling-patent-drug-of-novartis/articleshow/87483290.cms
https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china
https://endpts.com/novartis-whiffs-on-entresto-study-after-heart-attacks-but-that-doesnt-mean-its-going-down-quietly/
https://www.healio.com/news/cardiology/20210517/sacubitrilvalsartan-not-superior-to-valsartan-alone-in-advanced-hfref-life#:~:text=In%20patients%20with%20advanced%20HF,results%20of%20the%20LIFE%20trial.
https://www.fiercepharma.com/pharma/novartis-entresto-falls-short-post-heart-attack-trial
https://www.fiercepharma.com/marketing/where-do-you-stand-fda-reviewers-argue-for-novartis-entresto-committee-meeting-file
http://www.pmlive.com/pharma_news/cosentyx,_entresto_drive_topline_growth_for_novartis_in_q4_1323659
https://www.prnewswire.com/news-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref-300959592.html
http://www.pharmafile.com/news/525299/novartis-entresto-falls-short-phase-3-heart-failure-preserved-ejection-fraction
https://www.in-pharmatechnologist.com/Article/2019/02/25/Novartis-takes-on-RNA-targeting-cardio-drug
https://www.fiercepharma.com/pharma/novartis-narasimhan-wraps-up-eventful-first-year-as-ceo-rosy-outlook-planned
https://www.ema.europa.eu/documents/referral/sartans-article-31-referral-timetable-procedure_en.pdf
https://edition.cnn.com/2018/07/19/health/valsartan-recall-explainer/index.html
https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/valsartane-recall-update-productoverview.html
http://www.pmlive.com/pharma_news/real-world_data_finds_patients_feel_better_on_entresto,_says_novartis_1237350
http://www.pmlive.com/pharma_news/novartis_boosts_cardiovascular_pipeline_with_$1bn_ionis_deal_1183578
http://www.pharmatimes.com/Article/16-04-27/NICE_backs_restricted_use_of_heart_drug_Entresto.aspx
http://www.prnewswire.com/news-releases/novartis-heart-failure-medicine-entresto-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-300176067.html
http://www.marketwatch.com/story/novartis-new-heart-failure-medicine-entrestotm-recommended-by-chmp-for-eu-approval-2015-09-25
http://www.straitstimes.com/business/economy/swiss-giant-to-make-key-heart-failure-drug-here?
http://www.nasdaq.com/article/novartis-says-swissmedic-approves-entresto-in-heart-failure-20150918-00022?
http://www.fiercepharmamarketing.com/story/faster-track-megablockbuster-novartis-entresto-already-soaring-social-media/2015-09-16
http://www.forbes.com/sites/davidgrainger/2015/09/14/is-the-superiority-of-entresto-just-an-illusion/?ss=pharma-healthcare
http://www.prnewswire.com/news-releases/treato-finds-demand-will-be-high-for-heart-failure-drug-entresto-300139745.html
http://www.fiercepharma.com/story/novartis-ceo-payers-not-sold-performance-pricing-yet-thatll-change/2015-09-08
http://economictimes.indiatimes.com/news/international/business/novartis-to-start-human-tests-with-google-lens-in-2016/articleshow/48841183.cms?